NCT05236881

Brief Summary

This trial main purpose is to develop and test an mHealth app aimed at improving self-management, self-care and adherence of people with obesity. The study population are type I or II obese people, aged more than 18 years old, with or without comorbidities, who have a smartphone or tablet compatible with the app (Android version 9.0 or higher) and access to a scale for regular weight monitoring. Control group will follow standard care protocol and patients in the intervention group will also be provided with the app. Follow-up will be done for 16 weeks. Both groups will attend 3 face-to-face visits (baseline, 2 and 4 months).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P25-P50 for not_applicable obesity

Timeline
Completed

Started Apr 2022

Typical duration for not_applicable obesity

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 24, 2022

Completed
18 days until next milestone

First Posted

Study publicly available on registry

February 11, 2022

Completed
2 months until next milestone

Study Start

First participant enrolled

April 20, 2022

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 13, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2025

Completed
Last Updated

November 18, 2025

Status Verified

September 1, 2024

Enrollment Period

2.6 years

First QC Date

January 24, 2022

Last Update Submit

November 14, 2025

Conditions

Keywords

ObesitymHealthmobile applicationself-managementself-careadherence

Outcome Measures

Primary Outcomes (1)

  • %TWL at 4 months

    Percentage of total weight loss (%TWL) at 4 months

    4 months

Secondary Outcomes (15)

  • %TWL at 2 months

    2 months

  • %EWL at 2 and 4 months

    2 and 4 months

  • BMI change at 2 and 4 months

    Baseline, 2 and 4 months

  • Waist change at 2 and 4 months

    Baseline, 2 and 4 months

  • Blood pressure change at 2 and 4 months

    Baseline, 2 and 4 months

  • +10 more secondary outcomes

Study Arms (2)

ANíMATE mobile application

EXPERIMENTAL

Standard care protocol (3 face-to-face visits: basal, 2 and 4 months) + ANíMATE mobile application

Device: ANíMATE mobile application

Standard care

NO INTERVENTION

Standard care protocol (3 face-to-face visits: basal, 2 and 4 months)

Interventions

mHealth tool ANíMATE (Adherence, Nutrition, PhysIcal Activity, Motivation, medicAtion, Technology and Empowerment) allows the recording of data related to diet and exercise and feedback on behavior through an intelligent data analysis system.

ANíMATE mobile application

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients over 18 years of age.
  • People with BMI 30-39.9 kg/m2.
  • Have a smartphone or tablet compatible with the app (Android version 9.0 or higher) and have sufficient capabilities to use it.
  • Have access to a scale for regular weight monitoring.

You may not qualify if:

  • Presence of serious major comorbidities: High blood pressure treated with \> 3 drugs, diabetes mellitus treated with insulin, dyslipidemia treated with PCSK9 inhibitors, sleep apnea-hypopnea syndrome treated with CPAP, ischemic heart disease or stroke.
  • Use of pharmacological treatment with influence on weight started in the 6 months prior to study entry.
  • History of weight loss intervention (diet, exercise) in the 6 months prior to study entry.
  • History of eating disorder.
  • History of bariatric surgery.
  • Use of any other app or treatment to lose weight in the 6 months prior to study entry.
  • Pregnancy, short-term gestational desire or lactation.
  • Any other disease or condition that may interfere with compliance with the protocol or completion of the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital de la Santa Creu i Sant Pau

Barcelona, 08025, Spain

Location

MeSH Terms

Conditions

Obesity

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 24, 2022

First Posted

February 11, 2022

Study Start

April 20, 2022

Primary Completion

November 13, 2024

Study Completion

January 31, 2025

Last Updated

November 18, 2025

Record last verified: 2024-09

Locations